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Accepted 19 October 2007AbstractBackground: Quality of life (QoL) in breast cancer survivors has become increasingly important. However, QoL is often assessed using
a questionnaire meant to assess health status (HS). In this study the differences in outcomes between a HS and QoL questionnaire are shown
and the correlation between both questionnaires is assessed.
Methods: From the 140 breast cancer survivors that participated in the study, 68 received breast conserving therapy (BCT) and 72 were
treated with mastectomy (MTC). HS was measured using the RAND-36 and QoL was assessed with the WHOQOL-100. Scores were com-
pared with healthy reference populations.
Results: The scores on QoL in both treatment groups were comparable to those of healthy women. HS scores showed lower physical func-
tioning and general health perceptions for the MTC women. Pearson correlations between both questionnaires ranged between 0.19 and
0.75. Thus, the results of both questionnaires were not interchangeable.
Conclusion: A HS questionnaire reflects functional impairments and reveals different areas of concern compared with a QoL questionnaire.
The latter reflects the (dis)satisfaction of a patient and this seems not to mirror the functional limitations. Assessment of both objective
functioning and subjective appraisal of functioning will result in treatment suggestions that meet the patients needs.
 2007 Elsevier Ltd. All rights reserved.
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Introduction HS, HR-QoL, and QoL are often considered inter-Breast cancer is the predominant cancer in women in the
Western world with an incidence of 1 in 9 women who will
develop breast cancer during her life.1 Due to early detection
and extensive treatment options, for many patients breast
cancer has evolved from a deadly form of cancer to a chronic
disease.2 As a consequence, well-being has become a subject
of great interest for patients and physicians.3
Physical and psychological functioning are aspects of well-
being4 and can be measured using health status (HS) question-
naires. Quality of life (QoL) is another aspect of well-being4
and refers to satisfaction with different aspects of life.
The number of QoL-studies in breast cancer has in-
creased enormously in recent years, however a large num-
ber of these studies does not refer to QoL, but measures
health status or health-related QoL (HR-QoL).5* Corresponding author. Rubensstraat 91-2, 1077 MN Amsterdam, The
Netherlands. Tel.: þ31 62 123 4071; fax: þ31 13 536 3660.
E-mail address: lidekevdsteeg@isp.studenten.net (A.F.W. van der Steeg).
0748-7983/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejso.2007.10.009
Please cite this article in press as: van der Steeg AFW et al., The value of quality
of breast cancer survivors, Eur J Surg Oncol (2007), doi:10.1016/j.ejso.2007.10changeable, but these concepts are not the same.5 QoL is
defined by the World Health Organization Quality of Life
Group as ‘an individual’s perception of his position in
life in the context of the culture and value systems in which
he lives and in relation to his goals, expectations, standards
and concerns’.6 In other words, QoL is a person’s subjec-
tive evaluation of his functioning in a wide range of areas.
In a review Hughes et al. identified 14 frequently men-
tioned QoL domains: social relationships and interaction;
psychological well-being and personal satisfaction; em-
ployment; self-determination, autonomy, and personal
choice; recreation and leisure; personal competence, com-
munity adjustment and independent living skills; residential
environment; community integration; support services re-
ceived; individual and social demographic indicators; per-
sonal development and fulfillment; social acceptance,
social status, and ecological fit; physical and material
well-being; and civic responsibility.7 These domains are
considered to encompass the breadth of life experience.8of life and health status measurements in the evaluation of the well-being
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related domains such as physical functioning, psychologi-
cal well-being and personal satisfaction, and social rela-
tionships and interaction HR-QoL is measured.
HS measures the impact of disease on health related
functioning.9 Patients are asked about their physical possi-
bilities, social activities, and state of mind and not about
their (dis)contentment concerning their functioning. Thus,
HS indicates whether there are limitations, whereas
(HR)QoL also reflects to what extent a patient indicates
to be bothered by these limitations.
Depending on the research question, both HS and QoL can
be important to evaluate well-being in breast cancer survivors.
If the outcomes of interest are the possible long term effects of
breast cancer treatment on functioning, HS questionnaires are
sufficient. When the objective is to study satisfaction with
functioning, QoL questionnaires need to be used. Thus, it is
extremely important to recognize the different definitions of
both concepts and to realize that HS questionnaires are not
able to answer research questions concerning QoL.
The majority of studies concerning well-being in breast
cancer patients use more than one questionnaire to reach their
conclusions.5 This will provide a good insight into the well-
being of the women tested, as long as the distinction is made
between outcome scores from HS questionnaires and out-
come scores derived from QoL questionnaires.
This cross-sectional study was carried out to demon-
strate the difference between QoL and HS. The World
Health Organization Quality of Life Questionnaire (WHO-
QOL-100; a QoL questionnaire) and the RAND 36-Item
Health Survey (RAND-36; a HS questionnaire) were ad-
ministered to breast cancer survivors.
Two hypotheses were studied. The first hypothesis con-
cerns the difference in QoL and HS for breast cancer survi-
vors. We assumed that breast cancer survivors would not
have an impaired QoL due to (psychological) adjustment
to the given situation, whereas HS would still be impaired
because of continuing negative effects of breast cancer and
its treatment on functioning.
The second hypothesis concerns the correlation between the
WHOQOL-100 and the RAND-36. We assumed that the out-
come scores of the WHOQOL-100 (QoL) and the RAND-36
(HS) would not correlate well and that the scores on the two
questionnaires would not yield the same conclusions.
Based on previous studies that showed differences in
health status due to surgical treatment,10,11 the breast can-
cer survivors were divided in two treatment groups (breast
conserving therapy versus mastectomy).
Patients and methodsPatientsAll consecutive patients who were diagnosed with early
stage breast cancer and had surgical treatment between Jan-
uary 2000 and December 2001 were eligible for this study.Please cite this article in press as: van der Steeg AFW et al., The value of quality
of breast cancer survivors, Eur J Surg Oncol (2007), doi:10.1016/j.ejso.2007.10Women with proven breast cancer recurrence or distant
metastases were excluded, since it is known that recurrence
of breast cancer has a profound negative effect on QoL12,13
and would therefore compromise our results. One hundred
and seventy-eight women were contacted by telephone and
asked if they wanted to participate. Reasons for refusal
were ‘not interested’ (n ¼ 10), ‘too hard/do not want to
be confronted with the past’ (n ¼ 15), and ‘other reasons’
(n ¼ 7). One hundred and forty-six women agreed to partic-
ipate. Of these, 140 returned the questionnaires.
These 140 patients are a representative sample of the
Dutch early stage breast cancer patients. Treatment was ac-
cording to international guidelines and the proportion of the
two treatment groups is comparable with information from
the International Cancer Institute.14 For all patients, time
since diagnosis and surgical treatment was at least
54 months (range 54e66 months).Reference populationThe reference populations used for hypothesis 1 were
derived from the questionnaire manuals. For QoL the refer-
ence population existed of healthy Dutch women who lived
in the same residential area as the included breast cancer
survivors.15 The reference population for the HS were
healthy Dutch women who were comparable concerning
age and social status.16QuestionnairesQoL was assessed with the World Health Organization
Quality of Life assessment instrument-100 (WHOQOL-
100),15,17 a cross-culturally developed generic multi-dimen-
sional questionnaire.18 It consists of 100 items assessing 24
facets of QOL within six domains (Physical health, Psycho-
logical health, Level of independence, Social relationships,
Environment, Spirituality) and a general evaluative facet
(Overall quality of life and general health). The WHO-
QOL-100 was developed cross-culturally and simulta-
neously in 15 centers worldwide. Aspects of life that were
considered to contribute to QoL were discussed in focus
groups in each center. The inclusion of facets was eventually
based on a consensus within and between cultures among
health professionals, healthy individuals from the general
population and persons who were in contact with health ser-
vices because of disease or impairment.19 The response
scales for each question are 5-point scales and scores on
each facet and domain can range from 4 to 20. The timeframe
for evaluation when completing the questionnaire is the pre-
vious two weeks. The reliability and validity of the instru-
ment are good.19 In the present study the Cronbach alphas
for the domains ranged from 0.67 (domain Physical health;
3 facets) to 0.83 (domain Environment; 8 facets).
The RAND 36-Item Health Survey 1.0,20 Dutch Ver-
sion16 was used to assess health status. The RAND 36 is
practically identical to the Medical Outcome Study/Shortof life and health status measurements in the evaluation of the well-being
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3A.F.W. van der Steeg et al. / EJSO xx (2007) 1e6Form-36 (SF-36)21 and evaluates health in eight dimen-
sions: physical functioning, bodily pain, role limitations
due to physical health problems, role limitations due to per-
sonal or emotional problems, general mental health, social
functioning, vitality (energy/fatigue), and general health
perceptions. In addition, it includes a single item providing
an indication of perceived changes in health. The rationale
for these dimensions is that the health concepts are most
frequently included in widely-used health surveys. The
items used to measure the scores per dimension were adap-
ted from instruments that have been used for 20e40 years
or longer.21 Subscale scores are represented on a scale
from 0 to 100. A high score indicates a good health status.
The timeframe for evaluation of functioning is the previous
four weeks. The RAND-36 has a good reliability and valid-
ity.22 In the present study, the Cronbach alphas ranged from
0.79 (dimension social functioning; 2 items) to 0.92
(dimension physical functioning; 10 items).Statistical procedureFor examining differences between the two treatment
groups (breast conserving therapy (BCT) and mastectomy
(MTC)) with regard to clinical parameters of the tumor, sur-
gical treatment, adjuvant treatment, and the demographic
characteristics (children, living with a partner, educational
level), chi-square tests were employed. Analysis of variance
was performed to examine differences between the BCT and
MTC patients with regard to scores on QoL, its separate do-
mains, and the dimensions of the RAND-36. The scores on
overall QoL, the domains of QoL, and the dimensions of
the RAND were compared for each treatment group sepa-
rately with the scores of an existing reference population us-
ing one-sample t-tests. Due to the number of tests, p-values
smaller than 0.01 were considered statistically significant.
The association between the domains of the WHOQOL-
100 and the dimensions of the RAND-36 were examined
with Pearson correlation coefficients. All analyses were
performed with the Statistical Package for Social Sciences
(SPSS version 11.5).
ResultsTable 1
Clinical and demographic features for BCT and MTC group (includedCharacteristics of included patients
patients only)
BCT (n ¼ 68) MTC (n ¼ 72)
Age at diagnosis (SD) 54.9 (11.8) 58.2 (10.9)
Partner 55 55
Children 60 58
Level of education <6 yrs/6e10/
10e14/>14 yrs*
9/45/9/5 11/40/4/17The 140 included women were comparable to the 38
women who declined participation with respect to surgical
treatment and tumor characteristics. However, the partici-
pants were significantly younger ( p ¼ 0.003), more often
received chemotherapy ( p ¼ 0.048), and more often were
treated with radiotherapy ( p ¼ 0.047).Tumor size <1 cm/1e3 cm/>3 cm# 15/49/4 5/52/14
Lymphnode metastases yes/no** 14/46 30/33
Chemotherapy 16 27Characteristics of the two treatment groups
Hormone therapy** 22 39
Radiotherapy## 58 21
Note: *p < 0.05; **p < 0.01; #p ¼ 0.005; ##p < 0.001.
Sixty-eight women were treated with breast conserving
therapy (i.e. removal of the tumor by means ofPlease cite this article in press as: van der Steeg AFW et al., The value of quality
of breast cancer survivors, Eur J Surg Oncol (2007), doi:10.1016/j.ejso.2007.10a lumpectomy and axillary lymph node dissection followed
by radiation of the breast) and 72 women underwent a mas-
tectomy (i.e. removal of all breast tissue including the nip-
ple and axillary lymph node dissection).
Concerning demographic and clinical features there
were no differences in age, and having a partner or children
between the two treatment groups. Level of education
showed a significant difference. Compared with the BCT
group a larger percentage of the MTC group had had
more than 14 years of education ( p ¼ 0.031).
The clinical features showed differences regarding tu-
mor size, lymph node metastases, and adjuvant treatment.
The MTC group had significantly more large tumors
( p ¼ 0.005), had more lymph node metastases
( p ¼ 0.008), and more often received hormonal therapy
( p ¼ 0.01). Women in the BCT group were treated more
frequently with radiotherapy ( p < 0.001), as this was part
of the conserving treatment (Table 1).Quality of life and surgical treatmentScores on the facet overall QoL and the separate do-
mains of the WHOQOL-100 did not show significant differ-
ences between the two treatment groups. Compared with
the reference scores, the BCT group scored higher in the
psychological domain ( p < 0.001). There were no other
differences. (Table 2) The reference scores were derived
from the manuals of the WHOQOL-100 and the RAND-36.Health status and surgical treatmentScores on the dimensions of the RAND-36 showed no
significant differences between the BCT and MTC group.
Compared with scores from the reference population,
women in the MTC group scored lower on physical func-
tioning ( p ¼ 0.002), role limitations due to physical prob-
lems ( p ¼ 0.001), and general health perceptions
( p ¼ 0.007). The BCT group had a similar health status
as the reference population (Table 3).of life and health status measurements in the evaluation of the well-being
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Table 2
Scores of the BCT and MTC group on the different domains of the WHOQOL-100 and the reference scores
BCT MTC Reference score Results t-test
Overall QoL and general health 15.8 (2.4) 15.9 (2.7) 15.5 (3.2)
Physical domain 14.3 (2.8) 14.4 (2.5) 14.6 (2.7)
Psychological domain 15.4 (1.8) 14.9 (2.1) 14.4 (2.2) BCT: t ¼ 3.8, p < 0.001
Level of independence 15.4 (2.9) 15.5 (2.8) 16.8 (2.9)
Social relationships 15.5 (2.4) 15.4 (2.2) 15.3 (2.7)
Environment 16.1 (1.8) 16.3 (1.6) 15.8 (1.9)
Spiritual domain 12.5 (2.8) 12.5 (3.0) 13.0 (3.3)
Comparison between the scores by one-sample t-test (significant results shown in table). Note: standard deviation between brackets.
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4 A.F.W. van der Steeg et al. / EJSO xx (2007) 1e6Correlations between QoL and HS questionnairesFinally, correlations were calculated between the
RAND-36 and the WHOQOL-100.
Following Cohen,23 absolute correlations between 0.10
and 0.29 are considered small, between 0.30 and 0.49 me-
dium, and 0.50 and higher as large. Overall, the correlations
showed a considerable variety (Table 4). Corresponding do-
mains and dimensions were paired (see bold correlations in
Table 4). General health and Overall QoL showed a high
level of correlation. The QoL physical domain showed
a high correlation with the RAND dimension energy/fa-
tigue, but only a medium correlation with the dimension
physical functioning. Mental health and the psychological
domain had a high correlation, whereas the social domain
and social dimension only just reached medium correlation.
The highest correlation found was 0.75 (HS Energy/Fatigue
with QoL Physical domain), representing 56.3% common
variance.
DiscussionAim of studyThe aim of this study was to determine whether the
scores on QoL and HS of breast cancer survivors were com-
parable to scores of healthy reference populations and to es-
tablish the difference in conclusions reached when applying
a QoL questionnaire compared with a HS questionnaire.
Previous studies have compared different HS question-
naires to see whether the results are interchangeable whenTable 3
Scores of the BCT and MTC group on the different dimensions of the RAND-3
BCT MTC
General health perceptions 67.3 (20.6) 64.9 (20.1)
Physical functioning 76.3 (23.3) 71.2 (25.4)
Social functioning 79.3 (24.2) 84.4 (19.7)
Role limitations physical 71.0 (37.3) 61.4 (41.5)
Role limitations emotional 82.8 (30.7) 78.2 (36.8)
General mental health 78.3 (14.8) 74.4 (15.8)
Energy/fatigue 64.8 (21.3) 63.4 (18.6)
Bodily pain 77.2 (22.6) 75.3 (21.0)
Health changes 53.7 (18.6) 53.1 (20.9)
Comparison between the scores by one-sample t-test (significant results shown i
Please cite this article in press as: van der Steeg AFW et al., The value of quality
of breast cancer survivors, Eur J Surg Oncol (2007), doi:10.1016/j.ejso.2007.10applied to cancer patients.24,25,26,27 All studies showed con-
siderable differences in outcomes between the question-
naires used. So far there has not been a comparison of
a QoL and HS questionnaire in (breast) cancer patients.Results concerning QoLNo difference was found with regard to QoL between the
two treatment groups. As expected, the patients’ QoL was
not impaired when compared with the reference scores.
The BCT group scored better in the QoL psychological do-
main. A possible explanation for these results might be psy-
chological adaptation. Several studies have shown that
benefit finding in the diagnosis breast cancer and its treat-
ment result in better psychological adaptation and, thus,
better QoL.28,29 When breast cancer survivors were com-
pared with age-matched women with benign breast disease,
they reported poorer physical health and functioning, but no
differences in psychological stress and greater positive psy-
chological adaptation, such as improved life outlook.30Results concerning HSThe scores on the HS dimensions did not show signifi-
cant differences between the two treatment groups. How-
ever, compared with the reference scores the MTC group
scored significantly worse on general health perceptions,
physical functioning, and role limitations due to physical
problems. This concurs with our hypothesis. The results
of our study are in agreement with previous studies using
the RAND-36, that reported scores comparable to healthy6 and the reference scores
Reference score Results t-test
71.5 (21.8) MTC: t ¼ 2.8, p ¼ 0.007
80.7 (23.6) MTC: t ¼ 3.2, p ¼ 0.002
86.1 (20.9)
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Table 4
Pearson correlations between the individual domains of the WHOQOL-100 and the separate dimensions of the RAND-36
Overall QoL Phys. domain Psych. Domain Level of indep. Social domain Environ. Spiritual domain
General health 0.62 0.63 0.52 0.74 0.35 0.42 0.1*
Phys funct. 0.40 0.47 0.38 0.67 0.18 0.40 0.07*
Social funct. 0.50 0.62 0.46 0.63 0.30 0.41 <0.01*
Role lim. phys. 0.50 0.55 0.43 0.68 0.26 0.38 0.06*
Role lim. emot. 0.44 0.38 0.39 0.45 0.19 0.29 0.08*
Mental health 0.66 0.63 0.70 0.51 0.37 0.38 0.11*
Energy/fatigue 0.57 0.75 0.56 0.65 0.35 0.46 0.10*
Bodily pain 0.46 0.63 0.43 0.65 0.22 0.34 0.01*
Health changes 0.27 0.19 0.25 0.22 0.04* 0.14* 0.13*
Note: ) ¼ Correlations are not significant. All other correlations are significant at the 0.02 level (2-tailed) or 0.01 level (2-tailed).
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were more likely to have lower scores on the physical
health dimensions.32Consequences of study outcomesBased on the outcome of the WHOQOL-100, it may be
concluded that there is no long-term negative effect of breast
cancer on QoL in survivors who did not have a recurrence of
disease. However, the scores on the RAND-36 showed prob-
lems in the physical dimensions for the mastectomy group.
Thus, based on a QoL measure it can be concluded that no in-
tervention is needed, while treatment aimed at physical and
emotional functioning seems needed in the MTC group
when focusing on health status. The differences in outcome
scores in our study were also reflected in the Pearson correla-
tions. The highest correlation between the WHOQOL-100
and the RAND-36 was 0.75 for QoL physical health and
HS energy/fatigue, representing 56% of the variance, i.e.
slightly more than half of the variance, indicating that the out-
come measures are not interchangeable.
An illustrative example for the incompatibility of the
scores on both questionnaires in our study is the social do-
main from the WHOQOL-100 compared to the dimension
social functioning of the RAND-36. When physical limita-
tions or emotional problems cause a low number of social
activities or social contacts, the score on the dimension So-
cial functioning of the RAND-36 will be low. However,
a patient may be very satisfied with the nature of the social
contacts. Since the WHOQOL-100 does not inquire into the
number of social contacts but especially inquires about the
satisfaction concerning these social activities and the social
support, the score on the social domain of the WHOQOL-
100 may be high.
This means that attempts to improve the social life of pa-
tients based on a low score on social functioning with the
RAND-36 will probably not contribute to a better QoL, be-
cause the patients did not feel socially impaired.Literature overviewThe only studies we found that compared a QoL ques-
tionnaire to a HS questionnaire were performed by BreekPlease cite this article in press as: van der Steeg AFW et al., The value of quality
of breast cancer survivors, Eur J Surg Oncol (2007), doi:10.1016/j.ejso.2007.10et al. and O’Carroll et al.33,34 They administered both the
RAND-36 and the WHOQOL-100 to patients with intermit-
tent claudication33 and to patients following liver transplan-
tation.34 Both studies observed that although patients
reported significant impairment in all domains of HS,
QoL measurement showed that they did not consider all
objective functional impairments as a problem.
The differences in results of both questionnaires under-
score the importance of applying a questionnaire that is
able to answer the research questions posed. When using
a combination of measures of functioning and satisfaction,
the relation between functioning and satisfaction can be
studied most extensive. It has been argued that ideally
a combination of HS and QoL measures should be used, be-
cause they provide different information.30 In practice this
is hardly ever done, but it can be very useful in study de-
signs that are both interested in functional outcome of
a treatment, but also wish to assess the influence of treat-
ment on QoL. Such study questions can only be answered
correctly when using both types of questionnaires.ConclusionDisease-free breast cancer survivors report a good QoL
that illustrates a good adjustment to the diagnosis and treat-
ment of breast cancer. HS, however, is still impaired after
four to five years in women who received MST.
Based on these outcomes we feel that it is imperative to
conclude that HS questionnaires cannot be used to assess
QoL.
When researchers want to incorporate adjustment of
a patient to a given situation, a QoL questionnaire should
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